Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis

Thrombosis Research

Volumn 121, Issue 2, 2007, Pages 213-223

  Santos, Joana C ^a   Mesquita, Juliana M F ^a   Belmiro, Celso L R ^a   da Silveira, Carolina B M ^a   Viskov, Christian ^b   Mourier, Pierre A ^b   Pavão, Mauro S G ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b SANOFI   (France)

Author keywords

Antithrombotic effect; Arterio venous model; Ascidian; Dermatan sulfate; Heparin; Venous model

Indexed keywords

ALPHA LEVO IDURONIC ACID; ALPHA LEVO IDURONIC ACID 2 SULFATE; GLUCOSAMINE; HEPARIN; HEXURONIC ACID; HEXURONIC ACID 2 SULFATE; IDURONIC ACID; N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STYELA PLICATA; UROCHORDATA; VEIN THROMBOSIS;

EID: 36349000331     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.03.025     Document Type: Article

References (46)

1. Leyvraz P.F., Richard J., and Buchamann F. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 309 (1983) 954-958
2. Poller L. Therapeutic ranges in anticoagulant administration. Br Med J 290 (1985) 1683-1689
3. Mant M.J., O'Brien B.D., Thong K.L., Hammond G.W., Birtwhistle R.V., and Grace G.C. Haemorrhagic complications of heparin therapy. Lancet 1 (1997) 1133-1135
4. Salzman E.W., Deykin D., Shapiro R.M., and Rosemberg R.D. Management of heparin therapy-controlled prospective trial. N Engl J Med 292 (1975) 1046-1050
5. Lindahl U., Backstrom G., Thunberg L., and Leder I.G. Evidence for a 3-O-sulfated d-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A 77 (1980) 6551-6555
6. Casu B., Oreste P., Torri G., Zoppetti G., Choay J., Lormeau J.C., et al. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. Biochem J 197 (1981) 599-609
7. Ototani N., Kikuchi M., and Yosizawa Z. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies. Biochem J 205 (1982) 23-30
8. Thunberg L., Backstrom G., and Lindahl U. Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res 100 (1982) 393-410
9. Bjork I., and Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem 48 (1982) 161-182
10. Lindahl U., Thunberg L., Backstrom G., Riesenfeld J., Nordling K., and Bjork I. Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem 259 (1984) 12368-12376
11. Atha D.H., Stephens A.W., and Rosenberg R.D. Evaluation of critical groups required for the binding of heparin to antithrombin. Proc Natl Acad Sci U S A 81 (1984) 1030-1034
12. Atha D.H., Lormeau J.C., Petitou M., Rosenberg R.D., and Choay J. Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 24 (1985) 6723-6729
13. Jordan R.E., Oosta G.M., Gardner W.T., and Rosenberg R.D. The binding of low molecular weight heparin to hemostatic enzymes. J Biol Chem 255 (1980) 10073-10080
14. Dietrich C.P., de Paiva J.F., Moraes C.T., Takahashi H.K., Porcionatto M.A., and Nader H.B. Isolation and characterization of a heparin with high anticoagulant activity from Anomalocardia brasiliana. Biochim Biophys Acta 843 (1985) 1-7
15. Pejler G., Danielsson A., Bjork I., Lindahl U., Nader H.B., and Dietrich C.P. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J Biol Chem 262 (1987) 11413-11421
16. Dietrich C.P., Nader H.B., de Paiva J.F., Santos E.A., Holme K.R., and Perlin A.S. Heparin in mollusks: chemical, enzymatic degradation and 13C and 1H NMR spectroscopical evidence for the maintenance of the structure through evolution. Int J Biol Macromol 11 (1989) 361-366
17. Nader H.B., Chavante S.F., dos-Santos E.A., Oliveira T.W., de-Paiva J.F., Jeronimo S.M., et al. Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?. Braz J Med Biol Res 32 (1999) 529-538
18. Arumugam M., and Shanmugam A. Extraction of heparin and heparin-like substance from marine mesogastropod mollusc Turritella attenuata (Lamarck, 1779). Indian J Exp Biol 42 (2004) 529-532
19. Hovingh P., and Linker A. An unusual heparan sulfate isolated from lobsters (Homarus americanus). J Biol Chem 257 (1982) 9840-9844
20. Dietrich C.P., Paiva J.F., Castro R.A., Chavante S.F., Jeske W., Fareed J., et al. Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. Biochim Biophys Acta 1428 (1999) 273-283
21. Chavante S.F., Santos E.A., Oliveira F.W., Guerrini M., Torri G., Casu B., et al. A novel heparan sulphate with high degree of N-sulphation and high heparin cofactor-II activity from the brine shrimp Artemia franciscana. Int J Biol Macromol 27 (2000) 49-57
22. Tirumalai R., and Subramoniam T. Carbohydrate components of lipovitellin of the sand crab Emerita asiatica. Mol Reprod Dev 58 (2001) 54-62
23. Demir M., Iqbal O., Dietrich C.P., Hoppensteadt D.A., Ahmad S., Daud A.N., et al. Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I. Clin Appl Thromb Hemost 7 (2001) 44-52
24. Cavalcante M.C., Allodi S., Valente A.P., Straus A.H., Takahashi H.K., Mourao P.A., et al. Occurrence of heparin in the invertebrate Styela plicata (Tunicata) is restricted to cell layers facing the outside environment. An ancient role in defense?. J Biol Chem 275 (2000) 36189-86
25. Cavalcante M.C., de Andrade L.R., Du Bocage Santos-Pinto C., Straus A.H., Takahashi H.K., Allodi S., et al. Colocalization of heparin and histamine in the intracellular granules of test cells from the invertebrate Styela plicata (Chordata-Tunicata). J Struct Biol 137 (2002) 313-321
26. Pavao M.S. Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates. An Acad Bras Cienc 74 (2002) 105-112
27. Pavao M.S., Albano R.M., Lawson A.M., and Mourao P.A. Structural heterogeneity among unique sulfated l-galactans from different species of ascidians (tunicates). J Biol Chem 264 (1989) 9972-9979
28. Pavao M.S., Mourao P.A., and Mulloy B. Structure of a unique sulfated alpha-l-galactofucan from the tunicate Clavelina. Carbohydr Res 208 (1990) 153-161
29. Albano R.M., Pavao M.S., Mourao P.A., and Mulloy B. Structural studies of a sulfated l-galactan from Styela plicata (Tunicate): analysis of the Smith-degraded polysaccharide. Carbohydr Res 208 (1990) 163-174
30. Pavao M.S., Rodrigues M.A., and Mourao P.A. Acidic polysaccharides of the ascidian Styela plicata. Biosynthetic studies on the sulfated l-galactans of the tunic, and preliminary characterization of a dermatan sulfate-like polymer in body tissues. Biochim Biophys Acta 1199 (1994) 229-237
31. Pavao M.S., Mourao P.A., Mulloy B., and Tollefsen D.M. A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity. J Biol Chem 270 (1995) 31027-31036
32. Pavao M.S. Unique sulfated polysaccharides from ascidians (Chordata, Tunicata). Braz J Med Biol Res 29 (1996) 1227-1233
33. Pavao M.S., Aiello K.R., Werneck C.C., Silva L.C., Valente A.P., Mulloy B., et al. Highly sulfated dermatan sulfates from Ascidians. Structure versus anticoagulant activity of these glycosaminoglycans. J Biol Chem 273 (1998) 27848-27857
34. Cavalcante M.C., Mourao P.A., and Pavao M.S. Isolation and characterization of a highly sulfated heparan sulfate from ascidian test cells. Biochim Biophys Acta 1428 (1999) 77-87
35. Gandra M., Cavalcante M., and Pavao M. Anticoagulant sulfated glycosaminoglycans in the tissues of the primitive chordate Styela plicata (Tunicata). Glycobiology 10 (2000) 1333-1340
36. Cardoso L.E., and Mourao P.A. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 14 (1994) 115-124
37. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883 (1986) 173-177
38. Mourier P.A., and Viskov C. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases. Anal Biochem 332 (2004) 299-313
39. Vogel G.M., Meuleman D.G., Bourgondien F.G., and Hobbelen P.M. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. Thromb Res 54 (1989) 399-410
40. Herbert J.M., Herault J.P., Bernat A., van Amsterdam R.G., Vogel G.M., Lormeau J.C., et al. Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide" (SR 90107/ORG 31540) and standard heparin. Circ Res 79 (1996) 590-600
41. Bitter T., and Muir H.M. A modified uronic acid carbazole reaction. Anal Biochem 4 (1962) 330-334
42. Cesaretti M., Luppi E., Maccari F., and Volpi N. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site. Glycobiology 14 (2004) 1275-1284
43. Linhardt R.J., Ampofo S.A., Fareed J., Hoppensteadt D., Mulliken J.B., and Folkman J. Isolation and characterization of human heparin. Biochemistry 31 (1992) 12441-12445
44. Oscarsson L.G., Pejler G., and Lindahl U. Location of the antithrombin-binding sequence in the heparin chain. J Biol Chem 264 (1989) 296-304
45. De Candia E., De Cristofaro R., and Landolfi R. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin. Circulation 99 (1999) 3308-3314
46. de Barros C.M., Andrade L.R., Allodi S., Viskov C., Mourier P.A., Cavalcante M.C., et al. The hemolymph of the ascidian Styela plicata (Chordata-Tunicata) contains heparin inside basophil-like cells and a unique sulfated galactoglucan in the plasma. J Biol Chem 282 (2007) 1615-1626